These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26874021)

  • 1. Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders.
    Lu H; Kopcho L; Ghosh K; Witmer M; Parker M; Gupta S; Paul M; Krishnamurthy P; Laksmaiah B; Xie D; Tredup J; Zhang L; Abell LM
    Anal Biochem; 2016 May; 501():56-65. PubMed ID: 26874021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kynurenine aminotransferase II--reactivity with substrates and inhibitors.
    Passera E; Campanini B; Rossi F; Casazza V; Rizzi M; Pellicciari R; Mozzarelli A
    FEBS J; 2011 Jun; 278(11):1882-900. PubMed ID: 21439022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a microplate fluorescence assay for kynurenine aminotransferase.
    Wong J; Ray WJ; Kornilova AY
    Anal Biochem; 2011 Feb; 409(2):183-8. PubMed ID: 21059337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead discovery for human kynurenine 3-monooxygenase by high-throughput RapidFire mass spectrometry.
    Lowe DM; Gee M; Haslam C; Leavens B; Christodoulou E; Hissey P; Hardwicke P; Argyrou A; Webster SP; Mole DJ; Wilson K; Binnie M; Yard BA; Dean T; Liddle J; Uings I; Hutchinson JP
    J Biomol Screen; 2014 Apr; 19(4):508-15. PubMed ID: 24381207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
    Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
    Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Translational Analysis of Brain Kynurenic Acid Modulation via Irreversible Kynurenine Aminotransferase II Inhibition.
    Chang C; Fonseca KR; Li C; Horner W; Zawadzke LE; Salafia MA; Welch KA; Strick CA; Campbell BM; Gernhardt SS; Rong H; Sawant-Basak A; Liras J; Dounay A; Tuttle JB; Verhoest P; Maurer TS
    Mol Pharmacol; 2018 Aug; 94(2):823-833. PubMed ID: 29853495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia.
    Noorbakhsh A; Hosseininezhadian Koushki E; Farshadfar C; Ardalan N
    J Biomol Struct Dyn; 2022 Sep; 40(15):7038-7051. PubMed ID: 33645449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV.
    Douet V; Tanizaki N; Franke A; Li X; Chang L
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):549-61. PubMed ID: 27072370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead discovery for microsomal prostaglandin E synthase using a combination of high-throughput fluorescent-based assays and RapidFire mass spectrometry.
    Leveridge MV; Bardera AI; LaMarr W; Billinton A; Bellenie B; Edge C; Francis P; Christodoulou E; Shillings A; Hibbs M; Fosberry A; Tanner R; Hardwicke P; Craggs P; Sinha Y; Elegbe O; Alvarez-Ruiz E; Martin-Plaza JJ; Barroso-Poveda V; Baddeley S; Chung CW; Hutchinson J
    J Biomol Screen; 2012 Jun; 17(5):641-50. PubMed ID: 22337655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry.
    Hutchinson SE; Leveridge MV; Heathcote ML; Francis P; Williams L; Gee M; Munoz-Muriedas J; Leavens B; Shillings A; Jones E; Homes P; Baddeley S; Chung CW; Bridges A; Argyrou A
    J Biomol Screen; 2012 Jan; 17(1):39-48. PubMed ID: 21859681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine Aminotransferase Isozyme Inhibitors: A Review.
    Nematollahi A; Sun G; Jayawickrama GS; Church WB
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters.
    Jayawickrama GS; Nematollahi A; Sun G; Church WB
    PLoS One; 2018; 13(4):e0196404. PubMed ID: 29689093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis.
    Rossi F; Schwarcz R; Rizzi M
    Curr Opin Struct Biol; 2008 Dec; 18(6):748-55. PubMed ID: 18950711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives.
    Jayawickrama GS; Nematollahi A; Sun G; Gorrell MD; Church WB
    Sci Rep; 2017 Dec; 7(1):17559. PubMed ID: 29242525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
    Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
    J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling of human kynurenine aminotransferase III and observations on inhibitor binding using molecular docking.
    Nematollahi A; Church WB; Nadvi NA; Gorrell MD; Sun G
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):2-9. PubMed ID: 24739074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.